Age, Frailty, and Outcomes After Atrial Fibrillation Ablation: A Nationwide Cohort Study
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.70032 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Olayiwola Bolaji und 9 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers University New Jersey Medical School, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Frailty, Catheter Ablation, Frail Elderly. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Catheter ablation is a major treatment for atrial fibrillation (AF), but its outcomes in relation to age and frailty are not well understood, especially in an aging population.
Methods
A retrospective analysis of the 2016–2021 National Inpatient Sample database identified patients undergoing catheter ablation for AF. Patients were categorized by age and frailty status (low, intermediate, high). Multivariable logistic regression and propensity score matching were used to examine outcomes.
Results
Among 292,395 patients, 79.2% were aged 35–65 years, 15.7% were aged 66–79 years, and 5.1% were aged ≥ 80 years at the time of ablation. The proportion of patients aged ≥ 80 years increased from 11% in 2016% to 21.1% in 2021. Females comprised a higher proportion of the oldest age group (51.4%), but no sex differences were observed across frailty levels. In‐hospital mortality was highest in the high frailty group. Patients over 80 years had higher odds of cardiac rhythm restoration and pacemaker implantation but lower risks of cardiogenic shock, mechanical circulatory support, heart failure, myocardial infarction, and major adverse cardiac and cerebrovascular events (MACCE). Higher frailty was associated with an increased risk of in‐hospital mortality, complications, and MACCE.
Conclusions
Catheter ablation is increasingly performed in older patients. Advanced age and higher frailty are independently associated with adverse outcomes. These factors should be considered when evaluating patients for this procedure, and strategies to mitigate these risks should be explored.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rutgers University New Jersey Medical School, Newark, New Jersey, USA.
- ECU Health Medical Center, Greenville, North Carolina, USA.
- Wayne State University, Detroit, Michigan, USA.
- Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, New York, USA.
- Touro College of Osteopathic Medicine, Harlem, New York, USA.
- Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, Michigan, USA.
ORCID-Profile: Olayiwola Bolaji, Vishnu Shenoy, M Chadi Alraies
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Bolaji, O., Adabale, O., Bahar, Y., Echari, B., Shenoy, V., Phagoora, J., Bahar, A. R., Chadi Alraies, M., Ayinde, H., & Catanzaro, J. N. (2025). Age, Frailty, and Outcomes After Atrial Fibrillation Ablation: A Nationwide Cohort Study. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70032
Vancouver
Bolaji O, Adabale O, Bahar Y, Echari B, Shenoy V, Phagoora J, et al. Age, Frailty, and Outcomes After Atrial Fibrillation Ablation: A Nationwide Cohort Study. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.70032
BibTeX
@article{Bolaji2025,
author = {Bolaji, Olayiwola and Adabale, Olanrewaju and Bahar, Yasemin and Echari, Blanche and Shenoy, Vishnu and Phagoora, Jaskomal and Bahar, Abdul Rasheed and Chadi Alraies, M and Ayinde, Hakeem and Catanzaro, John N},
title = {Age, Frailty, and Outcomes After Atrial Fibrillation Ablation: A Nationwide Cohort Study},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.70032}
}
EUVIMED